| Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial BR Rubin, R Burton, S Navarra, J Antigua, J Londono, KG Pryhuber, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 267 | 2004 |
| Prevalencia de la enfermedad reumática en Colombia, según estrategia COPCORD-Asociación Colombiana de Reumatología. Estudio de prevalencia de enfermedad reumática en población … J Londoño, IP Ballestas, F Cuervo, I Angarita, R Giraldo, JC Rueda, ... Revista colombiana de reumatología 25 (4), 245-256, 2018 | 142* | 2018 |
| Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study MR McClung, ML O'Donoghue, SE Papapoulos, H Bone, B Langdahl, ... The lancet Diabetes & endocrinology 7 (12), 899-911, 2019 | 140 | 2019 |
| Use of a numerical rating scale as an answer modality in ankylosing spondylitis–specific questionnaires A Van Tubergen, I Debats, L Ryser, J Londoño, R Burgos‐Vargas, ... Arthritis Care & Research 47 (3), 242-248, 2002 | 139 | 2002 |
| Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies G Vargas-Alarcon, JD Londono, G Hernandez-Pacheco, R Gamboa, ... Annals of the rheumatic diseases 61 (1), 48-51, 2002 | 120 | 2002 |
| Periodontal disease in individuals with a genetic risk of developing arthritis and early rheumatoid arthritis: a cross‐sectional study JM Bello‐Gualtero, GI Lafaurie, LX Hoyos, DM Castillo, J De‐Avila, ... Journal of periodontology 87 (4), 346-356, 2016 | 113 | 2016 |
| Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index … MH Cardiel, JD Londoño, E Gutiérrez, C Pacheco-Tena, ... Clinical and experimental rheumatology 21 (4), 451-458, 2003 | 100 | 2003 |
| Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis … G Huerta-Sil, JC Casasola-Vargas, JD Londoño, R Rivas-Ruíz, J Chávez, ... Annals of the rheumatic diseases 65 (5), 642-646, 2006 | 95 | 2006 |
| Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients G Vargas-Alarcón, JD Londono, G Hernandez-Pacheco, C Pacheco-Tena, ... Annals of the rheumatic diseases 61 (8), 714-717, 2002 | 76 | 2002 |
| Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis L Candia, J Marquez, C Gonzalez, AM Santos, J Londono, R Valle, ... JCR: Journal of Clinical Rheumatology 12 (5), 226-229, 2006 | 62 | 2006 |
| Association between Th-17 cytokine profile and clinical features in patients with spondyloarthritis C Romero-Sanchez, DA Jaimes, J Londoño, J De Avila, JE Castellanos, ... Clinical and Experimental Rheumatology-Incl Supplements 29 (5), 828, 2011 | 61 | 2011 |
| Tumor necrosis factor-α promoter polymorphisms in mexican patients with spondyloarthritis G Vargas-Alarcón, J Casasola-Vargas, JM Rodríguez-Pérez, G Huerta-Sil, ... Human immunology 67 (10), 826-832, 2006 | 57 | 2006 |
| Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis G Vargas-Alarcón, R Gamboa, J Zuñiga, JM Fragoso, ... Human immunology 65 (12), 1437-1442, 2004 | 52 | 2004 |
| Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis C Romero-Sánchez, WH Robinson, BH Tomooka, J Londoño, ... Clinical rheumatology 27, 1429-1435, 2008 | 48 | 2008 |
| Spondyloarthropaty characterization and factors determination of bad prognostic in a Colombian patients population JD Londono P, LA Gonzalez, LA Ramirez, P Santos, M Avila, AM Santos, ... Revista Colombiana de Reumatologia 12 (3), 195-207, 2005 | 48* | 2005 |
| The association between serum levels of potential biomarkers with the presence of factors related to the clinical activity and poor prognosis in spondyloarthritis J Londono, MC Romero-Sanchez, VG Torres, WA Bautista, DJ Fernandez, ... Revista Brasileira de Reumatologia 52, 536-544, 2012 | 45 | 2012 |
| Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns J Londono, AM Santos, P Peña, E Calvo, LR Espinosa, JD Reveille, ... BMJ open 5 (11), e009092, 2015 | 36 | 2015 |
| Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis JGB Muñoz, RB Giraldo, AM Santos, JM Bello-Gualteros, JC Rueda, ... Clinical rheumatology 36, 1143-1148, 2017 | 34 | 2017 |
| Pharmacogenetics of methotrexate in rheumatoid arthritis: a systematic review LF Restrepo, R Giraldo, J Londoño, C Pinzón, A Cortes, G Ballesteros, ... Revista Colombiana de Reumatología (English Edition) 23 (2), 102-114, 2016 | 29* | 2016 |
| Therapeutic efficacy and safety of methotrexate+ leflunomide in Colombian patients with active rheumatoid arthritis refractory to conventional treatment J Londono, AM Santos, PI Santos, MF Cubidez, C Guzman, R Valle-Oñate Revista Brasileira de Reumatologia 52, 837-845, 2012 | 29* | 2012 |
Juan C. Rueda, MD, PhD (c)Médico Internista, ReumatólogoVerified email at unisabana.edu.co
